Back to search

Netherlands· NL-26f117632eb6

Phoxilium 1,2 mmol/l fosfaat oplossing voor hemodialyse/hemofiltratie

A hemofiltrates product containing calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + dinatriumwaterstoffosfaat 2-water (e 339), registered in Netherlands by Vantive Belgium SRL. The same ATC class is registered in 11 of our 19 countries.

ATC B05ZB

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPhoxilium 1,2 mmol/l fosfaat oplossin…ATCB05ZBREGISTER NO.NL-26f117632eb6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + dinatriumwaterstoffosfaat 2-water (e 339) is registered in 11 of 19 countries.

Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + dinatriumwaterstoffosfaat 2-water (e 339) · ATC B05ZB

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CALCIUM (Ca2+) + CALCIUMCHLORIDE 2-WATER (E 509) + CHLORIDE (CL-) + DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)
Manufacturer
Vantive Belgium SRL
Country
Netherlands (NL)
ATC code
B05ZB
ATC class
Hemofiltrates
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    101928

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abfb105b-83df-44dd-be9e-e5e8b29c1811
GET /v1/drugs/abfb105b-83df-44dd-be9e-e5e8b29c1811?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor hemofiltratie, Oplossing voor hemodialyse",
  "route": "Intraveneus gebruik, Hemodialyse",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h101928_smpc.pdf",
  "strength": null,
  "atc_label": "Hemofiltrates",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg101928",
  "excipients": [
    "KOOLSTOFDIOXIDE (E 290)",
    "WATER VOOR INJECTIE",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CALCIUM (Ca2+)",
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "CHLORIDE (CL-)",
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "KALIUM (K+)",
    "KALIUMCHLORIDE (E 508)",
    "MAGNESIUM (MG2+)",
    "MAGNESIUMCHLORIDE 6-WATER (E 511)",
    "MONOWATERSTOFFOSFAAT (HPO4 2-)",
    "NATRIUM (NA+)",
    "NATRIUMCHLORIDE",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "WATERSTOFCARBONAAT (HCO3-)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h101928.pdf",
  "authorised_at": "2009/08/19",
  "procedure_number": "NL/H/1147/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "101928",
  "additional_monitoring": "N"
}

See everything about calcium (ca2+) + calciumchloride 2-water (e 509) + chloride (cl-) + dinatriumwaterstoffosfaat 2-water (e 339).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.